Tyra Biosciences (TYRA) Competitors $7.74 -0.56 (-6.75%) Closing price 04:00 PM EasternExtended Trading$7.72 -0.02 (-0.26%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TYRA vs. CGON, ARQT, IRON, KYMR, ARWR, APGE, AGIO, GLPG, KNSA, and JANXShould you be buying Tyra Biosciences stock or one of its competitors? The main competitors of Tyra Biosciences include CG Oncology (CGON), Arcutis Biotherapeutics (ARQT), Disc Medicine (IRON), Kymera Therapeutics (KYMR), Arrowhead Pharmaceuticals (ARWR), Apogee Therapeutics (APGE), Agios Pharmaceuticals (AGIO), Galapagos (GLPG), Kiniksa Pharmaceuticals (KNSA), and Janux Therapeutics (JANX). These companies are all part of the "pharmaceutical products" industry. Tyra Biosciences vs. CG Oncology Arcutis Biotherapeutics Disc Medicine Kymera Therapeutics Arrowhead Pharmaceuticals Apogee Therapeutics Agios Pharmaceuticals Galapagos Kiniksa Pharmaceuticals Janux Therapeutics Tyra Biosciences (NASDAQ:TYRA) and CG Oncology (NASDAQ:CGON) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, community ranking, earnings, analyst recommendations, dividends and valuation. Do institutionals and insiders believe in TYRA or CGON? 84.1% of Tyra Biosciences shares are owned by institutional investors. Comparatively, 26.6% of CG Oncology shares are owned by institutional investors. 15.4% of Tyra Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts rate TYRA or CGON? Tyra Biosciences presently has a consensus price target of $30.83, suggesting a potential upside of 298.36%. CG Oncology has a consensus price target of $63.88, suggesting a potential upside of 271.37%. Given Tyra Biosciences' higher possible upside, research analysts plainly believe Tyra Biosciences is more favorable than CG Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00CG Oncology 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10 Does the MarketBeat Community prefer TYRA or CGON? Tyra Biosciences received 12 more outperform votes than CG Oncology when rated by MarketBeat users. However, 92.31% of users gave CG Oncology an outperform vote while only 76.60% of users gave Tyra Biosciences an outperform vote. CompanyUnderperformOutperformTyra BiosciencesOutperform Votes3676.60% Underperform Votes1123.40% CG OncologyOutperform Votes2492.31% Underperform Votes27.69% Which has higher valuation & earnings, TYRA or CGON? CG Oncology has higher revenue and earnings than Tyra Biosciences. CG Oncology is trading at a lower price-to-earnings ratio than Tyra Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTyra BiosciencesN/AN/A-$69.13M-$1.51-5.13CG Oncology$1.14M1,150.95-$48.61M-$1.42-12.11 Does the media refer more to TYRA or CGON? In the previous week, CG Oncology had 12 more articles in the media than Tyra Biosciences. MarketBeat recorded 29 mentions for CG Oncology and 17 mentions for Tyra Biosciences. Tyra Biosciences' average media sentiment score of 0.49 beat CG Oncology's score of 0.27 indicating that Tyra Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tyra Biosciences 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral CG Oncology 6 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Is TYRA or CGON more profitable? Tyra Biosciences has a net margin of 0.00% compared to CG Oncology's net margin of -10,642.98%. CG Oncology's return on equity of -18.97% beat Tyra Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Tyra BiosciencesN/A -24.56% -23.31% CG Oncology -10,642.98%-18.97%-15.36% Which has more risk and volatility, TYRA or CGON? Tyra Biosciences has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, CG Oncology has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. SummaryCG Oncology beats Tyra Biosciences on 11 of the 18 factors compared between the two stocks. Remove Ads Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TYRA vs. The Competition Export to ExcelMetricTyra BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$391.67M$6.32B$5.24B$7.07BDividend YieldN/A2.85%4.87%4.05%P/E Ratio-4.816.7221.2017.47Price / SalesN/A186.91356.3585.24Price / CashN/A65.6738.1634.64Price / Book1.635.576.233.79Net Income-$69.13M$141.67M$3.20B$247.10M7 Day Performance-20.78%-11.44%-8.32%-7.32%1 Month Performance-29.32%-14.59%-3.36%-10.20%1 Year Performance-57.00%-18.30%2.72%-7.41% Tyra Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TYRATyra Biosciences1.8157 of 5 stars$7.74-6.7%$30.83+298.4%-52.8%$391.67MN/A-4.8120Analyst RevisionGap DownHigh Trading VolumeCGONCG Oncology1.0665 of 5 stars$24.49-7.3%$63.88+160.8%-51.2%$1.86B$684,000.00-17.2561Analyst RevisionNews CoverageGap DownARQTArcutis Biotherapeutics3.0784 of 5 stars$15.64-0.6%$18.80+20.2%+67.8%$1.86B$196.54M-8.74150Analyst ForecastNews CoverageGap DownIRONDisc Medicine3.0642 of 5 stars$49.64-5.2%$93.80+89.0%+50.1%$1.81BN/A-12.4730Positive NewsGap DownHigh Trading VolumeKYMRKymera Therapeutics1.2112 of 5 stars$27.37-7.6%$56.36+105.9%-36.2%$1.78B$47.07M-11.70170News CoverageGap DownARWRArrowhead Pharmaceuticals3.0528 of 5 stars$12.74-7.8%$41.44+225.3%-54.5%$1.75B$2.50M-2.46400Gap DownHigh Trading VolumeAPGEApogee Therapeutics2.0043 of 5 stars$37.36-5.9%$92.17+146.7%-41.7%$1.68BN/A-15.4491Insider TradeNews CoverageGap DownAGIOAgios Pharmaceuticals4.3585 of 5 stars$29.30-3.2%$56.57+93.1%-2.7%$1.68B$36.50M2.58390Short Interest ↓News CoveragePositive NewsGLPGGalapagos0.4275 of 5 stars$25.12-1.3%$25.33+0.8%-24.2%$1.66B$275.65M0.001,123KNSAKiniksa Pharmaceuticals2.5176 of 5 stars$22.21-3.8%$37.17+67.3%+19.3%$1.61B$423.24M-158.63220Positive NewsGap DownJANXJanux Therapeutics2.0411 of 5 stars$27.00-7.2%$92.44+242.4%-25.7%$1.60B$10.59M-23.0830Gap Down Remove Ads Related Companies and Tools Related Companies CGON Alternatives ARQT Alternatives IRON Alternatives KYMR Alternatives ARWR Alternatives APGE Alternatives AGIO Alternatives GLPG Alternatives KNSA Alternatives JANX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TYRA) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TYRA Stock Free TYRA Stock Alerts